Steven Inglis
Research Subjects
Research Interests
Steven Inglis has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Liew
AI & Data Science
2 shared publications - Jon Bowles
Oxford PharmaGenesis Oxford United Kingdom
2 shared publications - Julliana Newman
Gilead Sciences Melbourne Australia
2 shared publications - Kelly Soady
PharmaGenesis London London United Kingdom
2 shared publications D. Draper
Department of Obstetrics and Gynecology University of Colorado Health Science Center Denver CO USA
1 shared publicationJ. Jeremias
Department of Obstetrics and Gynecology Cornell University Medical College 515 East 71st Street New York NY 10021 USA
1 shared publication
Latest Publications
- Open Access
- 27 August 2021
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 23 (8) , e29168
Podcasts for the Delivery of Medical Education and Remote Learning
Podcasts are increasingly being recognized as an effective platform to facilitate the continuous professional development (CPD) of health care professionals (HCPs). Compared with face-to-face meetings and other more traditional forms of CPD, podcasts allow for flexible learning and are less expensive to develop. Podcasts are at the cutting edge of digital education and can be an important element of a pharmaceutical company’s multichannel communications plan to improve HCP engagement and CPD in specific therapy areas. However, developing a successful podcast can have significant challenges. In this viewpoint paper, we provide our perspectives on medical podcasts as a medium for educating HCPs in the digital age. We describe our experience in developing an HIV-focused podcast for Australian HCPs, creating a series that has now expanded to other therapy areas in several countries. Practical considerations and unique challenges associated with industry-sponsored podcasts are outlined. Overall, we believe that the process of developing a podcast can be a challenging but rewarding experience, and CPD delivered via podcasting should be more routinely considered by pharmaceutical companies.
- 27 August 2021
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 23 (8) , e29168
Open AccessPodcasts for the Delivery of Medical Education and Remote Learning
Podcasts are increasingly being recognized as an effective platform to facilitate the continuous professional development (CPD) of health care professionals (HCPs). Compared with face-to-face meetings and other more traditional forms of CPD, podcasts allow for flexible learning and are less expensive to develop. Podcasts are at the cutting edge of digital education and can be an important element of a pharmaceutical company’s multichannel communications plan to improve HCP engagement and CPD in specific therapy areas. However, developing a successful podcast can have significant challenges. In this viewpoint paper, we provide our perspectives on medical podcasts as a medium for educating HCPs in the digital age. We describe our experience in developing an HIV-focused podcast for Australian HCPs, creating a series that has now expanded to other therapy areas in several countries. Practical considerations and unique challenges associated with industry-sponsored podcasts are outlined. Overall, we believe that the process of developing a podcast can be a challenging but rewarding experience, and CPD delivered via podcasting should be more routinely considered by pharmaceutical companies.
- Open Access
- 7 April 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Podcasts for the Delivery of Medical Education and Remote Learning (Preprint)
UNSTRUCTURED Podcasts are increasingly being recognized as an effective platform to facilitate the continuous professional development (CPD) of health care professionals (HCPs). Compared with face-to-face meetings and other more traditional forms of CPD, podcasts allow for flexible learning and are less expensive to develop. Podcasts are at the cutting edge of digital education and can be an important element of a pharmaceutical company’s multichannel communications plan to improve HCP engagement and CPD in specific therapy areas. However, developing a successful podcast can have significant challenges. In this viewpoint paper, we provide our perspectives on medical podcasts as a medium for educating HCPs in the digital age. We describe our experience in developing an HIV-focused podcast for Australian HCPs, creating a series that has now expanded to other therapy areas in several countries. Practical considerations and unique challenges associated with industry-sponsored podcasts are outlined. Overall, we believe that the process of developing a podcast can be a challenging but rewarding experience, and CPD delivered via podcasting should be more routinely considered by pharmaceutical companies.
- 7 April 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPodcasts for the Delivery of Medical Education and Remote Learning (Preprint)
UNSTRUCTURED Podcasts are increasingly being recognized as an effective platform to facilitate the continuous professional development (CPD) of health care professionals (HCPs). Compared with face-to-face meetings and other more traditional forms of CPD, podcasts allow for flexible learning and are less expensive to develop. Podcasts are at the cutting edge of digital education and can be an important element of a pharmaceutical company’s multichannel communications plan to improve HCP engagement and CPD in specific therapy areas. However, developing a successful podcast can have significant challenges. In this viewpoint paper, we provide our perspectives on medical podcasts as a medium for educating HCPs in the digital age. We describe our experience in developing an HIV-focused podcast for Australian HCPs, creating a series that has now expanded to other therapy areas in several countries. Practical considerations and unique challenges associated with industry-sponsored podcasts are outlined. Overall, we believe that the process of developing a podcast can be a challenging but rewarding experience, and CPD delivered via podcasting should be more routinely considered by pharmaceutical companies.
- Open Access
- 1 January 1994
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 2 (1) , 16-19
Detection of Trichomonas vaginalis Using the Polymerase Chain Reaction in Pregnant andNon‐Pregnant Women
Objective:Trichomonas vaginalis vaginal infections are often both asymptomatic and difficult to detect by current methods. We evaluated the ability of a newly developed polymerase chain reaction (PCR) assay to identify T. vaginalis in vaginal samples from pregnant and non‐pregnant women.Methods: In the 1st study, we compared the prevalence of T. vaginalis detection by PCR and culture using Diamond′s medium in 52 women with symptoms of vaginal infection. In the 2nd study, T. vaginalis was detected using PCR and wet mount microscopy in 131 asymptomatic pregnant women.Results: Among the women with symptoms of vaginitis, 7 (13.5%) were PCR‐positive for T. vaginalis. Six of the PCR‐positive women, but none of the PCR‐negative women, were culture‐positive for this organism. All but 1 of the women with candidal vaginitis or bacterial vaginosis were PCR‐negative for T. vaginalis. Among the asymptomatic pregnant women, all of whom were negative for T. vaginalis by wet mount, l0 (7.6%) were PCR‐positive for T. vaginalis.Conclusions: PCR offers a rapid and sensitive alternative to culture and microscopy for the detection of T. vaginalis vaginal infections in both symptomatic and asymptomatic women.
- 1 January 1994
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 2 (1) , 16-19
Open AccessDetection of Trichomonas vaginalis Using the Polymerase Chain Reaction in Pregnant andNon‐Pregnant Women
Objective:Trichomonas vaginalis vaginal infections are often both asymptomatic and difficult to detect by current methods. We evaluated the ability of a newly developed polymerase chain reaction (PCR) assay to identify T. vaginalis in vaginal samples from pregnant and non‐pregnant women.Methods: In the 1st study, we compared the prevalence of T. vaginalis detection by PCR and culture using Diamond′s medium in 52 women with symptoms of vaginal infection. In the 2nd study, T. vaginalis was detected using PCR and wet mount microscopy in 131 asymptomatic pregnant women.Results: Among the women with symptoms of vaginitis, 7 (13.5%) were PCR‐positive for T. vaginalis. Six of the PCR‐positive women, but none of the PCR‐negative women, were culture‐positive for this organism. All but 1 of the women with candidal vaginitis or bacterial vaginosis were PCR‐negative for T. vaginalis. Among the asymptomatic pregnant women, all of whom were negative for T. vaginalis by wet mount, l0 (7.6%) were PCR‐positive for T. vaginalis.Conclusions: PCR offers a rapid and sensitive alternative to culture and microscopy for the detection of T. vaginalis vaginal infections in both symptomatic and asymptomatic women.